<?xml version="1.0" encoding="UTF-8"?>
<p>The capability of naringenin to alter glucose homeostasis in the brain has been recently studied. This can pave the way for a better understanding of insulin-dependent and -independent mechanisms involved in experimental diabetes. Pre-treatment with naringenin in epileptic mice has revealed its anti-epileptic potential as it curbs different oxidative stress biomarkers with the improvement in behavioral parameters [
 <xref rid="B4-plants-09-01784" ref-type="bibr">4</xref>].
</p>
